USFDA closes Dr Reddy's Hyderabad facility inspection with VAI status
Dr Reddy's Laboratories has said the US health regulator classified the inspection outcome of its formulations manufacturing facility here as 'Voluntary Action Indicated (VAI)' and officially closed the inspection. In a regulatory filing on Saturday, the company said the Good Manufacturing Practices (GMP) inspection was conducted by the USFDA at its formulations manufacturing facility (FTO-3) in Bachupally, Hyderabad. The company had earlier informed the stock exchanges regarding the inspection…




